LSD1 has been found to be highly expressed in liver cancer, lung cancer, breast cancer, and prostate cancer, and promotes the growth and invasion of cancer cells by participating in a variety of chromatin epigenetic modifications [14,28,29,30]. Here, KDM1A is linked to breast carcinoma.